Allergan Aesthetics, an AbbVie company, showcased its new AA Signature multimodal treatment approach to a global audience. The presentation took place at the Aesthetic & Anti-Ageing Medicine World Congress (AMWC) in Dubai from October 1–3, 2025.
After launching across 25 countries this year, Allergan Aesthetics is expanding the AA Signature approach globally. The programme integrates its diverse product portfolio with advanced clinical education and practice resources for healthcare professionals.
The evidence-based methodology supports treatment protocols such as Lift Up, Distinct Definition, and Skin Quality Enhancement, designed to address diverse patient needs.
Expert insights at AMWC Dubai
The Allergan Medical Institute (AMI) hosted a symposium at AMWC Dubai titled “Design Your Patients’ Look with the NEW Signature Approach by Allergan Aesthetics and a Decade of MD Codes™ Excellence.” The event brought together global experts to explore evolving trends in aesthetic medicine and the new AA Signature™ approach.
Renowned experts, including Dr Mauricio de Maio, creator of the MD Codes™ system, lead discussions on the evolving paradigm in aesthetic medicine. They performed a live AA Signature™ Lift Up injection to demonstrate how multimodal treatments restore lift, definition, and firmness.
Allergan Aesthetics’ Global Medical Affairs team led the symposium “Mastering Skin Quality” to advance holistic aesthetic innovations. The session highlighted the company’s ongoing commitment to advancing skin quality science. With 94% of people seeking improved facial skin quality, experts shared insights on advanced multimodal treatments. Dr Rami Abadi, Dr Sylwia Godlewska, Dr Maurizio Cavallini, and Dr Mansi Mukherjee explained how hyaluronic acid, biostimulators, and hybrid injectables can work together.
Engaging sessions and scientific contributions
Over three days, experts at booth B100 led practical sessions on AA Signature™ protocols, patient engagement, and the SKIN360 framework.
In addition, seven new e-posters were accepted for presentation, reflecting the company’s leadership in personalised aesthetics. Experts discussed nonsurgical lift effects with multimodal injectables, skin quality improvement, and infraorbital rejuvenation using hyaluronic acid fillers and botulinum toxin. They also presented HArmonyCa™ safety and efficacy results.
Driving global innovation
The debut of AA Signature™ at AMWC Dubai reinforces Allergan Aesthetics’ commitment to advancing scientific, personalised, and holistic approaches in aesthetic medicine. Through multimodal innovation, education, and real-world evidence, the company continues to support practitioners in elevating standards of care.